PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

Neurofibrosarcoma

Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion Tazemetostat in Malignant Peripheral Nerve Sheath Tumors A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST) Alisertib in Treating Patients With Advanced or Metastatic Sarcoma Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors Vaccine Therapy in Treating Patients With Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery A Study of Pembrolizumab in Patients With Malignant Peripheral Nerve Sheath Tumor (MPNST), Not Eligible for Curative Surgery Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors